PL373052A1 - Polipeptydy fuzyjne glikoprotein płytek IB alfa isposoby ich stosowania - Google Patents

Polipeptydy fuzyjne glikoprotein płytek IB alfa isposoby ich stosowania

Info

Publication number
PL373052A1
PL373052A1 PL02373052A PL37305202A PL373052A1 PL 373052 A1 PL373052 A1 PL 373052A1 PL 02373052 A PL02373052 A PL 02373052A PL 37305202 A PL37305202 A PL 37305202A PL 373052 A1 PL373052 A1 PL 373052A1
Authority
PL
Poland
Prior art keywords
platlet
glycoprotein
methods
fusion polypeptides
alpha fusion
Prior art date
Application number
PL02373052A
Other languages
English (en)
Inventor
Gray D. Shaw
Ravindra Kumar
Dianne S. Sako
Tom Mcdonagh
Francis X. Sullivan
Original Assignee
Genetics Institute, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute, Llc filed Critical Genetics Institute, Llc
Publication of PL373052A1 publication Critical patent/PL373052A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL02373052A 2001-02-06 2002-02-06 Polipeptydy fuzyjne glikoprotein płytek IB alfa isposoby ich stosowania PL373052A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26683801P 2001-02-06 2001-02-06

Publications (1)

Publication Number Publication Date
PL373052A1 true PL373052A1 (pl) 2005-08-08

Family

ID=23016192

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02373052A PL373052A1 (pl) 2001-02-06 2002-02-06 Polipeptydy fuzyjne glikoprotein płytek IB alfa isposoby ich stosowania

Country Status (16)

Country Link
US (5) US6991796B2 (pl)
EP (1) EP1360292A2 (pl)
KR (1) KR20030074796A (pl)
CN (1) CN100523188C (pl)
AR (1) AR035779A1 (pl)
AU (3) AU2002240287B2 (pl)
BR (1) BR0207039A (pl)
CA (1) CA2437714A1 (pl)
HU (1) HUP0303167A2 (pl)
IL (1) IL157264A0 (pl)
MX (1) MXPA03007010A (pl)
NO (1) NO20033474L (pl)
NZ (1) NZ528037A (pl)
PL (1) PL373052A1 (pl)
WO (1) WO2002063003A2 (pl)
ZA (1) ZA200306229B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
CN100436480C (zh) 2003-06-11 2008-11-26 韦思公司 血小板糖蛋白IB-α变体融合多肽及其用法
JP2005073528A (ja) * 2003-08-28 2005-03-24 Genetics Inst Llc 生物学的系における生物学的組織への血球の接着を阻害する方法、ならびにその方法に使用するための組成物
US8039588B2 (en) * 2004-05-21 2011-10-18 The Uab Research Foundation Variable lymphocyte receptors
US20080015145A1 (en) 2006-07-11 2008-01-17 Maria Gyongyossy-Issa Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions
DE102007031708A1 (de) * 2007-07-06 2009-01-08 Dade Behring Marburg Gmbh Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin
WO2010071934A1 (en) * 2008-12-22 2010-07-01 Baker Idi Heart And Diabetes Institute Holdings Limited Modulation of platelet activation
CN102988983B (zh) * 2011-09-09 2014-06-11 苏州苏大赛尔免疫生物技术有限公司 抗人血小板膜糖蛋白Ibα嵌合抗体药物组合物
WO2013096932A1 (en) * 2011-12-23 2013-06-27 Vasculogics, Inc. Compositions and methods for treatment of thrombosis and prolonging survival of stored platelets
AU2013283409B2 (en) 2012-06-26 2017-06-08 Ge Healthcare As Preparation of composition comprising gas microbubbles
ES2614352T3 (es) * 2014-03-11 2017-05-30 Siemens Healthcare Diagnostics Products Gmbh Método para la detección de moduladores de la interacción de GPIb-trombina
CN107340225B (zh) * 2017-07-13 2019-07-05 徐州医科大学 一种基于流式细胞术检测血小板受体GPIba胞外段酶切的方法
EP4386387A2 (en) 2018-02-20 2024-06-19 F. Hoffmann-La Roche AG Composition comprising recombinant gpiba receptor protein

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
IL88308A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides that block the binding of von willebrand factor
US5225538A (en) 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5462990A (en) * 1990-10-15 1995-10-31 Board Of Regents, The University Of Texas System Multifunctional organic polymers
US6136310A (en) 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US6277975B1 (en) * 1992-10-23 2001-08-21 Genetics Institute, Inc. Fusions of P-selectin ligand protein and polynucleotides encoding same
US5516964A (en) 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
JP3735921B2 (ja) * 1996-02-07 2006-01-18 三菱ウェルファーマ株式会社 ＧＰＩｂ・脂質複合体およびその用途
ES2532910T3 (es) * 1998-04-02 2015-04-01 Genentech, Inc. Variantes de anticuerpos y fragmentos de los mismos
EP1074564B1 (en) * 1998-04-23 2008-12-10 Ajinomoto Co., Inc. Substance with antithrombotic activity and method for detecting glycokallidin
AR035779A1 (es) * 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
US6878881B1 (en) * 2004-09-08 2005-04-12 Stephen K. Henry Modular cable protector assembly

Also Published As

Publication number Publication date
US6991796B2 (en) 2006-01-31
HUP0303167A2 (hu) 2003-12-29
CN100523188C (zh) 2009-08-05
NZ528037A (en) 2006-08-31
US20030232047A1 (en) 2003-12-18
WO2002063003A3 (en) 2003-05-15
AU2011200943A1 (en) 2011-03-24
IL157264A0 (en) 2004-02-19
US20030091576A1 (en) 2003-05-15
KR20030074796A (ko) 2003-09-19
US20090148427A1 (en) 2009-06-11
ZA200306229B (en) 2005-05-26
AU2006241373A1 (en) 2006-12-14
AR035779A1 (es) 2004-07-14
US20060140935A1 (en) 2006-06-29
US20060093614A1 (en) 2006-05-04
CA2437714A1 (en) 2002-08-15
CN1553955A (zh) 2004-12-08
EP1360292A2 (en) 2003-11-12
BR0207039A (pt) 2005-05-03
WO2002063003A2 (en) 2002-08-15
NO20033474L (no) 2003-10-02
NO20033474D0 (no) 2003-08-05
MXPA03007010A (es) 2004-07-08
AU2002240287B2 (en) 2006-08-24
US7049128B2 (en) 2006-05-23

Similar Documents

Publication Publication Date Title
HK1095152A1 (en) Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
IL160706A0 (en) Peptides acting as both glp-1 receptor agonists and their pharmacological methods of use
HK1072373A1 (en) Virus coat protein/receptor chimeras and methods of use
IL158751A0 (en) Recombinant fusion proteins and the trimers thereof
IL157142A0 (en) Modified antibodies and methods of use
EP1435911A4 (en) PRODUCTS WITH PROTEIN MATRIX MATERIALS AND METHOD FOR THEIR PRODUCTION AND USE
IL153970A0 (en) Promyostatin peptides and methods of using same
IL210257A0 (en) Remodeling and glycoconjugation of peptides
EP1451217A4 (en) NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES
PL373052A1 (pl) Polipeptydy fuzyjne glikoprotein płytek IB alfa isposoby ich stosowania
PL376673A1 (pl) Białka fuzyjne mutein interferonu alfa o ulepszonych właściwościach
HK1154504A1 (en) Chemokine receptor antagonists and methods of use thereof
AU2002364699A8 (en) Receptors and membrane-associated proteins
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1441030A4 (en) METHOD OF PURIFYING RECOMBINANT FUSED PROTEIN AND PROTEIN PRODUCTION PROCESS USING THE PURIFICATION PROCESS
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1357128A4 (en) PREPARATION AND USE OF A PLASMODIUM FUSION ANTIGEN
EP1423402A4 (en) NOVEL ANALOGUES OF POLYPEPTIDES AND HYBRID PROTEINS AND METHODS OF USE
EP1406921A4 (en) HYPOGLYCAEMIC PEPTIDES AND METHOD FOR USE THEREOF
AU2002359252A1 (en) Human tyrosine-dna phosphodiesterase variant polypeptides and methods of use therefor
AU2003222262A8 (en) Arrestin gene, polypeptide and methods of use thereof
EP1549951A4 (en) SEMAPHORIN-LIKE PROTEINS AND METHODS OF USE THEREOF
AU2002245311A8 (en) Human protein kinase n-like polypeptide and uses thereof
AU2002311898A1 (en) Recombinant bicistronic flaviviruses and methods of use thereof
AU2003262895A8 (en) Carboxypeptidase b related polypeptides and methods of use

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)